Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1996-11-7
|
pubmed:abstractText |
Both IL-12 and IFN-gamma have been implicated as principal inducers of type 1 immune responses required for the elimination of intracellular pathogens, such as viruses. We examined the in vivo antiviral role of both cytokines during coronavirus-induced hepatitis in a mouse hepatitis virus (MHV) model. The absence of IFN-gamma function in mice with a targeted disruption of the IFN-gamma R alpha-chain gene (IFN-gamma R -/-) resulted in increased susceptibility to coronaviral hepatitis associated with augmented viral replication and increased hepatocellular injury. The mutant mice showed a type 1 lymphokine response characterized by the normal high IFN-gamma and low IL-4 production. Unlike MHV-infected wild-type mice, however, the mutant IFN-gamma R -/- mice showed no increase in IL-12 p4O gene expression, similar to that in naive animals. IL-12 treatment failed to restore host resistance in IFN-gamma R -/- mice, but significantly protected MHV-susceptible C57BL/6 mice against lethal infection, although less than IFN-gamma treatment. Mice protected by IL-12 or IFN-gamma showed resistance against an otherwise lethal second MHV infection. Our data demonstrate that despite reduced IL-12 gene expression and defective IFN-gamma R function, virus-induced IFN-gamma production can occur. Furthermore, they emphasize the pivotal antiviral role of IFN-gamma in protection against acute coronavirus-induced hepatitis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interferon,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/interferon gamma receptor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
157
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
815-21
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:8752933-Acute Disease,
pubmed-meshheading:8752933-Animals,
pubmed-meshheading:8752933-Antigens, CD,
pubmed-meshheading:8752933-Base Sequence,
pubmed-meshheading:8752933-Female,
pubmed-meshheading:8752933-Hepatitis, Viral, Animal,
pubmed-meshheading:8752933-Immunosuppressive Agents,
pubmed-meshheading:8752933-Interferon-gamma,
pubmed-meshheading:8752933-Interleukin-12,
pubmed-meshheading:8752933-Male,
pubmed-meshheading:8752933-Mice,
pubmed-meshheading:8752933-Mice, Inbred C57BL,
pubmed-meshheading:8752933-Mice, Mutant Strains,
pubmed-meshheading:8752933-Molecular Sequence Data,
pubmed-meshheading:8752933-Receptors, Interferon,
pubmed-meshheading:8752933-Recombinant Proteins
|
pubmed:year |
1996
|
pubmed:articleTitle |
Exacerbated viral hepatitis in IFN-gamma receptor-deficient mice is not suppressed by IL-12.
|
pubmed:affiliation |
Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
|
pubmed:publicationType |
Journal Article
|